A growing body of evidence suggests that nobiletin (5,6,7,8,3,4-hexamethoxy flavone) from the peel of citrus fruits, enhances the damaged cognitive function in disease animal models. However, the neuroprotective mechanism has not been clearly elucidated. Since nobiletin has shown anti-inflammatory effects in several tissues, we investigated whether nobiletin suppresses excessive microglial activation implicated in neurotoxicity in lipopolysaccharide (LPS)-stimulated BV-2 microglia cell culture models. Release of nitric oxide (NO), the major inflammatory mediator in microglia, was markedly suppressed in a dose-dependent manner following nobiletin treatment (1-50 mM) in LPS-stimulated BV-2 microglia cells. The inhibitory effect of nobiletin was similar to that of minocycline, a well-known microglial inactivator.
Neuronal cell damage and death are attributed to the pathogenesis of neurodegenerative diseases and functional deterioration. Cognitive deficit shown in Alzheimer's disease (AD) is related to cell death of cholinergic neurons in basal forebrain, 1, 2) dopaminergic neuronal cell death is related to Parkinson's disease (PD), 3, 4) and motor neuronal cell death is related to amyotrophic lateral sclerosis (ALS).
5) The functional loss consequential to stroke could depend on the location and size of the ischemic area in the brain. 6, 7) Microglial cells, the resident immune cells of the brain, exert a role of immune surveillance and host defense under physiological conditions. However, excessive microglial activation with overproduction of nitric oxide (NO) and proinflammatory cytokines, such as interleukin-1b (IL-1b), interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) has been shown to be an important cause of neuronal cell death, and is implicated in neuroinflammation and neurodegeneration.
Microglial activation precedes neuronal cell death in several brain diseases including ischemia. [8] [9] [10] Therefore, microglia-mediated neurotoxicity is a crucial molecular mechanisms associated with neuronal cell death, damage, and functional deterioration. Suppression of microglial activation has been suggested as a potential therapeutic target to alleviate the progression of neuroinflammatory and neurodegenerative diseases. 11, 12) In the case of stroke, early blockade of microglial activation could be a very effective treatment since it inhibits delayed neuronal cell death in the penumbra region of brain ischemia and as such could provide a therapeutic time window to alleviate further brain damage following initial neuronal cell death in an ischemic core area. 13, 14) Microglial activation and subsequent neuroinflammation-mediated neurotoxicity is implicated as a target of therapeutic intervention not only in acute stroke injuries but also in chronic neurodegenerative diseases such as ischemia-reperfusion injury, PD, AD, and ALS. [15] [16] [17] [18] Many compounds from natural resources have been investigated as candidates for drug development. The anti-inflammatory and anti-oxidative activities of citrus fruit peel extracts were evaluated in peripheral inflammatory cells, RAW 264.7 a murine macrophage cell line, and correlated with the content of nobiletin, a polymethoxylated flavones. 19, 20) Nobiletin exerted the most potent inhibitory activity of NO in the RAW 264.7 cells among the tested flavonoids (naringin, naringenin, hesperidin, hesperetin, rutin, tangeretin and nobiletin) found in citrus fruit feels. 20) Recent evidence suggests that citrus nobiletin is active in the central nervous system. Citrus nobiletin has neurotrophic activity which induces neurites outgrowth by activating a cAMP response element (CRE) transcription-dependent signaling pathway in PC12D cells, 21) improving memory deterioration in MK-801-treated mice, olfactory bulbectomyinduced mice, 22) and a transgenic AD mouse model. 23) No-biletin improved ischemia-induced learning and memory deficits through stimulation of calcium/calmodulin-dependent protein kinase II (CaMKII) and cyclic AMP-response element binding protein (CREB) phosphorylation. 24) The fact that nobiletin may suppress microglial activation has not yet been reported. Therefore, we investigated whether citrus nobiletin suppress microglial activation implicated in neuroinflammation and neurotoxicity in lipopolysaccharide (LPS)-stimulated BV-2 microglia. This study explores the therapeutic potential and molecular mechanism of nobiletin against neuroinflammation and neurodegeneration.
MATERIALS AND METHODS
Cell Culture BV-2 microglia, immortalized murine microglia cell line, exhibit phenotypic and functional properties comparable to those of primary microglia and hippocampal neurons. 25, 26) BV-2 cells were obtained from Dr. E. Joe (Ajou University, Korea). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and kept at 37°C in a humidified atmosphere of 5% CO 2 . The cells were seeded in 6-well plates (1.2ϫ10 6 cells/well, Corning, U.S.A.) or 60 mm culture dishes (3ϫ10 6 cells/well, Corning, U.S.A.). Reagents Nobiletin, from the peel of Citrus sunki HORT. ex TANAKA, a nobiletin-rich citrus fruit, was isolated at the Jeju National University, Department of Biology. 19) Nobiletin purchased from Sigma was also used to compare activity. DMEM, FBS, penicillin, and streptomycin were obtained from Gibco BRL (U.S.A.). All other reagents were purchased from Sigma, unless indicated.
Lactate Dehydrogenase Release (LDH) Assay LDH is released into culture media upon damage to the cytoplasmic membrane, oxidizes lactate to pyruvate which reacts with iodonitrotetrazolium to form formazan (red). Therefore, the increase in the amount of formazan produced in culture media directly correlates with an increase in the number of lysed cells. The cytotoxicity of nobiletin was measured with an LDH cytotoxicity detection kit (Takara Shuzo Co., Japan) to determine the pharmacological dose for trial. BV-2 microglial cells were seeded on 96-well plates at 2ϫ 10 4 cells/well. Following a 12 h stabilization period, the cells were treated with different concentrations of nobiletin for 26 h. A 50 ml sample of supernatant was exposed to a 50 ml LDH mixture and absorbance was read at 492 nm on a microplate reader. LDH release was then expressed as % of maximal LDH release measured after lysis of the cells with 0.5% Triton X-100.
MTT Cell Viability Assay MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] was used to examine the effect of nobiletin on cell viability. MTT (yellow) is reduced to formazan (purple) by mitochondrial succinyl dehydrogenase in living cells. Therefore, the amount of formazan produced in cytoplasm is directly correlated with cell viability. BV-2 microglial cells were seeded on 24-well plates at 1ϫ10 5 cells per well containing 500 ml medium. After treatment, 250 ml MTT (2 mg/ml) was added to each well and the mixture further incubated for 2 h. The liquid in each well was then aspirated and 500 ml dimethyl sulfoxide (DMSO) was added, mixed thoroughly on a shaker for 30 min. Absorbance was subsequently read at 540 nm using a microplate reader (Model 550, Bio-Rad, U.S.A.).
NO Quantification The accumulation of NO 2 Ϫ , a stable end product, extensively used as an indicator of NO production, was assayed using the Griess reagent. BV-2 microglial cells were seeded on 24-well tissue culture plates at 1ϫ10 5 cells/well containing medium (500 ml) and then incubated with LPS (200 ng/ml) for 24 h in the presence or absence of nobiletin. The supernatants were mixed with equal amounts of Griess reagent. Samples were incubated at room temperature for 10 min and absorbance was subsequently read at 540 nm using a microplate reader (Model 550, BioRad, U.S.A.).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA was isolated using Tri reagent (Molecular Research Center Inc., U.S.A.) according to the manufacturer's instructions. Briefly, 1 mg of total RNA was incubated in a tube containing 100 U of SuperScript II Reverse Transcriptase (Invitrogen, U.S.A.), 100 U RNaseOUT (Invitrogen), 250 mM deoxyribonucleotide triphosphate (dNTPs), and 0.5 mM oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer for 15 min at 70°C. The reaction was terminated by heating the mixture at 70°C for 5 min followed by cooling on ice. The RNA strands in the RNA-DNA hybrid were removed by adding 10 U RNaseH (Invitrogen, U.S.A.) and incubating for 45 min at 42°C. Polymerase chain reaction (PCR) was performed in a total volume of 25 ml containing 3 ml cDNA, 200 mM dNTPs, 20 pmol of each primer pair, and 3 U Taq DNA polymerase (iNtRON, U.S.A.) in Taq DNA polymerase reaction buffer as provided by the supplier. A total of 30 cycles were run under the following schemes; denaturing at 94°C for 40 s, primer annealing at 50°C (TNF-a) and 55°C glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and an extension step at 72°C for 1 min in the Peltier Thermal Cycler (PTC)-100 (BIO-RAD, U.S.A.). The following sets of primers were used in the PCR amplifications: TNF-a (forward 5Ј-ATGAGCACAGAAAG-CATGAT-3Ј, reverse 5Ј-TGACTTTCTCCTGGTATGA-3Ј), GAPDH (forward 5Ј-GTCCACATTGTTGCCATCAACG-AC-3Ј, reverse 5Ј-TTTCTCGTGGTTCACACCCATCAC-3Ј). The expected PCR products were 507 bp for TNF-a and 336 bp for GAPDH, respectively. PCR products were separated electrophoretically on 1% agarose gel, stained with ethidium bromide, and subsequently visualized under UV illumination. Optical densities of the PCR bands for TNF-a were quantified with an Image J analyzer (http://rsb.info. nih.gov/ij/) and normalized with those of GAPDH.
Western Blotting Analysis Cells were washed once with phosphate-buffered saline (PBS; pH 7.4) and lysed with modified radio-immunoprecipitation assay (RIPA) buffer (10 mM Tris-HCl; pH 7.4, 150 mM NaCl, 1 mM ethylene glycol bis(2-aminoethylether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), 0.1% sodium dodecyl sulfate (SDS), 1 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml aprotinin, and 1 mg/ml leupeptin). Protein (50 mg) was separated in 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane using Towbin transfer buffer (192 mM glycine, 25 mM Tris, and 20% methanol; pH 8.3). The blots were incubated with 5% skim milk in TTBS (25 mM Tris, 150 mM NaCl, pH 7.4, containing 0.1% Tween 20) for 2 h at room temperature to block nonspecific binding. Subsequently, the membranes were probed with anti-extracellular signal-regulated kinase (ERK) and anti-phospho-ERK (1 : 1000, Santa Cruz Biotechnology Inc., U.S.A.), antip38 and anti-phospho-p38 (1 : 1000, Cell Signaling Laboratories, U.S.A.), anti-c-Jun NH 2 -terminal kinase (JNK) and anti-phospho JNK (1 : 1000, Cell Signaling Laboratories, U.S.A.), anti-inducible nitric oxide synthase (iNOS) (1 : 1000, Cell Signaling Laboratories, U.S.A.), anti-cyclooxygenase-2 (COX-2) (1 : 1000, Cell Signaling Laboratories, U.S.A.), nuclear factor kB p65 (NF-kB p65) (1 : 500, Santa Cruz Biotechnology Inc., U.S.A.), anti-inhibitory kB (IkB)a (1 : 500, Santa Cruz Biotechnology Inc., U.S.A.) and anti-b-actin antibody (1 : 5000, Cell Signaling Laboratories, U.S.A.). The blots were washed 3 times with TTBS and incubated with horseradish peroxidase (HRP)-conjugated antimouse immunoglobulin G (IgG) antibody or anti-rabbit IgG secondary antibody (1 : 5000, Vector Laboratories, U.S.A.). After several washes, the blots were developed using an enhanced chemiluminescence reagent (Amersham Biosciences, U.S.A.) according to the manufacturer's instructions. Optical densities of the band were quantified with an Image J analyzer (http://rsb.info.nih.gov/ij/) and normalized with those of b-actin.
Cytoplasmic and Nuclear Protein Preparations Cells were harvested from culture dishes with trypsin and centrifuged at 12000ϫg for 5 min at 4°C. Cell pellets were washed twice with ice-cold PBS and resuspended in ice-cold hypotonic buffer [10 mM Hepes (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), 10 mg/ml aprotinin, 0.2 mM PMSF]. Following incubation on ice for 10 min, the cytoplasmic extract was obtained as supernatant by centrifuging for 5 min and then stored at Ϫ80°C until use. Nuclear pellets were resuspended in ice-cold high-salt buffer [20 mM Hepes (pH 7.9), 20% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF] for 40 min, and centrifuged for 10 min. The supernatant nuclear protein extract was stored at Ϫ80°C until use.
Enzyme Linked Immunosorbent Assay (ELISA) The amount of pro-inflammatory cytokines released into the culture medium were measured using mouse TNF-a and IL-1b ELISA kits based on the quantitative sandwich enzyme immunosorbent technique. The assay was performed according to the manufacturer's protocol (Invitrogen, U.S.A.). In brief, 50 ml of each sample or standard and 50 ml of biotinylated anti-mouse TNF-a and IL-1b antibody were incubated for 90 min on a 96-well ELISA plate pre-coated with anti-mouse monoclonal TNF-a and IL-1b antibody. After 4 washes, horseradish peroxidase (HRP)-conjugated secondary antibody was incubated for 30 min. After 4 additional washes, chromogen solution was incubated for 30 min in the dark after which the peroxidase-catalyzed color change was stopped by adding stop solution. The absorbance was read at a wavelength of 450 nm using a microplate reader (Model 550, Bio-Rad, U.S.A.).
Fluorescent Immunocytochemistry BV-2 microglial cells were seeded on 12 mm-diameter cover glass (0.3ϫ 10 5 cells/glass). After treatment, cells were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 30 min and permeabilized in 0.5% triton X-100 in PBS for 15 min. Nonspecific binding was blocked with 5% normal goat serum in PBS for 30 min. Subcellular localization of NF-kB was examined using rabbit polyclonal antibody against NF-kB p65 (1 : 500, Santa Cruz Biotechnology Inc., U.S.A.) and Alexa Fluor 488-conjugated goat anti-rabbit antibody (1 : 400, Invitrogen, U.S.A.). Nuclear counterstaining was performed with Hoechst 33342 (1 : 2000, Invitrogen, U.S.A.). Prolong kit (Invitrogen, U.S.A.) was used to reduce fading. Cells were imaged on a confocal laser scanning microscope (FV500, Olympus Optical Co., Japan) with a cooled charge-coupled device camera, controlled by Flow View 4.2 software (Olympus Optical Co., Japan).
Statistical Analysis Data are expressed as mean valueϮstandard error of mean (S.E.M.) of at least 3 independent experiments. Statistical analyses were performed using the t-test and one-way ANOVA. The differences between groups were considered to be statistically significant when pϽ0.05.
RESULTS

Cytotoxicity Test of Nobiletin
Cytotoxicity of nobiletin was examined using a LDH release assay and MTT assay. Cells were treated for 26 h with different concentrations of nobiletin. Nobiletin did not show any cytotoxicity at concentrations less than 100 mM (Fig. 1B) ; therefore, most experiments were accomplished at a concentration of 50 mM of nobiletin on the basis of the cytotoxic dose information and dose-dependency of NO production (Fig. 2) .
Inhibitory Effects of Nobiletin on iNOS Expression and NO Release in LPS-Stimulated BV-2 Microglia NO production has been the most widely used representative indicator of microglial activation among many inflammatory mediators. The iNOS expression was generated in activated mi- croglial cells, mediating synthesis of NO, which were then released into culture medium. The inhibitory effect of nobiletin on iNOS expression and NO release in LPS-stimulated BV-2 microglia was evaluated using Western blotting analysis and a nitrite assay (Fig. 2) . BV-2 microglial cells were treated with LPS (100 ng/ml) in the presence or absence of nobiletin for 24 h. A 2 h pretreatment with nobiletin was carried out prior to LPS stimulation. Nobiletin treatment (50 mM) significantly inhibited LPS-induced iNOS expression by 71.2Ϯ10.7%, when compared to the LPS alone-treated group (Fig. 2A) . Nobiletin treatment (50 mM) also significantly inhibited protein expression of proinflammatory enzyme cyclooxygenase-2 (COX-2) by 46.0Ϯ6.7% in LPS-stimulated microglia (data not shown). Nobiletin treatment (1, 10, 30, 50 mM) markedly suppressed LPS-induced NO release in a dose-dependent manner by 13.3Ϯ4.0%, 45.1Ϯ3.4%, 74.1Ϯ4.9% and 86.6Ϯ7.2% respectively (Fig. 2B) . The inhibitory effect of nobiletin was similar to that of minocycline, a well-known microglia inactivator 13) (Fig. 2C) . Inhibitory Effects of Nobiletin on TNF-a and IL-1b Production in LPS-Stimulated BV-2 Microglia Proinflammatory cytokines are soluble mediators of inter-and intra-cellular communication which occurs during inflammatory responses. The effect of nobiletin on proinflammatory cytokine release was investigated in LPS-stimulated BV-2 microglial cells treated with LPS (100 ng/ml) in the presence or absence of nobiletin (50 mM) for 24 h. Cells were pretreated with nobiletin for 2 h prior to LPS stimulation. RT/PCR, Western blotting, and ELISA analyses demonstrated that TNF-a mRNA expression (Fig. 3A) , TNF-a protein expression (Fig. 3B ) and TNF-a release into culture medium (Fig. 3C) were markedly increased 525.4Ϯ3.5%, 395.4Ϯ4.3% and 872.0Ϯ6.4% in the LPS-stimulated microglia group compared to unstimulated control group, and significantly suppressed in the nobiletin-treated group by 52.5Ϯ2.3%, 59.0Ϯ11.6% and 46.3Ϯ8.6% compared to the LPS alone-treated group. IL-1b release (Fig. 3D) were also increased 255.1Ϯ1.8% in the LPS-stimulated group and significantly suppressed by 14.9Ϯ0.9% in the nobiletin-treated group.
Inhibitory Effects of Nobiletin on Phosphorylation of ERK, JNK and p38 MAPKs in LPS-Stimulated BV-2 Microglia
Following a 24 h nobiletin pretreatment, BV-2 microglial cells were treated with LPS (100 ng/ml) in the presence or absence of nobiletin (50 mM) for 30 min. After LPS stimulation, phosphorylations of mitogen-activated protein kinases (MAPKs) including ERK, JNK and p38 were investigated to determine whether they were involved in nobiletin's mechanism of action. Cell lysates were prepared and subjected to 10% SDS-PAGE followed by Western blotting analysis with antibodies specific for phosphorylated forms of ERK, JNK and p38 MAPK.
Phosphorylations of ERK (Fig. 4B), p38 (Fig. 4C ) and JNK (Fig. 4D) were markedly increased in the LPS-stimulated microglia group 159.8Ϯ9.5%, 297.2Ϯ8.3%, and 169.5Ϯ4.2% respectively, compared to the control microglia group without LPS treatment. However, nobiletin treatment significantly attenuated the phosphorylation levels of ERK, p38, and JNK by 30.9Ϯ3.6%, 37.0Ϯ7.0%, and 21.2Ϯ2.0% respectively, compared to the LPS alone-treated group (Fig  4) .
Upon activation, microglia show hypertrophic morpholological changes, increased motility, and the capacity to release inflammatory mediators such as NO and proinflammatory cytokines. 27) Since LPS-induced activation of MAPK such as ERK, p38, and JNK may be involved early in initiating the microglial activation processes, the suppressive effect of LPS-induced MAPK phosphorylation may be important in evaluating the effect of nobiletin on inhibiting microglial activation. 
Inhibitory Effects of Nobiletin on NF-kB Signaling in
LPS-Stimulated BV-2 Microglia
The signaling pathways of the major proinflammatory transcription factor NF-kB are well established. 19) Briefly, NF-kB is localized in the cytoplasm and bound to the inhibitory protein IkB in resting microglia. Microglia activation evokes IkB kinase (IKK) complex-induced phosphorylation of IkB, which leads to its degradation and subsequent translocation of NF-kB to the nucleus. The nuclear NF-kB activates the transcription of target genes which have NF-kB-binding sites, such as TNFa, IL-1b and iNOS. 11, 12) Therefore, we analyzed whether nobiletin affects LPS-induced IkB degradation and NF-kB translocation to the nucleus and subsequent nuclear NF-kB expression levels.
Following 24 h of nobiletin pretreatment, BV-2 microglial cells were treated with LPS (100 ng/ml) in the presence or absence of nobiletin for the indicated times (15, 30 min, 1, 2 h). After LPS stimulation, total cellular protein was isolated and subjected to 10% SDS-PAGE followed by Western blotting analysis with antibodies specific for IkBa. In addition, nuclear protein fraction was also isolated (see Materials and Methods) to investigate NF-kB expression in the nucleus.
IkBa levels were markedly decreased with LPS treatment by 21.4Ϯ1.4% at the 15 min time point and maximally decreased by 56.7Ϯ13.7% at the 30 min time point compared to the unstimulated control group, suggesting LPS-induced IkB degradation. The reduced IkBa levels recovered to 69.6Ϯ12.7% at the 1 h time point and 79.2Ϯ6.0% at the 2 h time point, compared to the unstimulated control group (Fig.  5A) . Nobiletin treatment did not affect IkBa levels in our experiment (Fig. 5B) . Western blotting analysis with nuclear protein fraction demonstrated that NF-kB p65 subunit levels were dramatically increased 188.5Ϯ5.7% in the nuclei of the BV-2 microglia group stimulated with LPS for 30 min and nobiletin treatment significantly suppressed LPS-induced NF-kB p65 subunit expression in the nucleus by 29.0Ϯ8.5% compared to the LPS alone-treated group (Fig. 5C) .
Fluorescent immunocytochemistry data visually demonstrated AF488 (green)-labeled NF-kB p65 subunit immunoreactivities shown in cytoplasms peripheral to the nuclei counterstained with Hoechst 33342 (blue) in the control microglia group (Figs. 5D-1-3 ). In the BV-2 microglia group stimulated with LPS for 30 min, NF-kB p65 subunit immunoreactivities were shown in the nuclei and barely found in the cytoplasms, suggesting translocation of NF-kB to the nucleus (Figs. 5D-4-6 ). Nobiletin treatment markedly reversed nuclear translocation of the LPS-induced NF-kB p65 subunit (Figs. 5D-7-9 ).
DISCUSSION
We investigated whether nobiletin suppresses brain insultinduced excessive microglial activation implicated in neuroinflammation and neurotoxicity. The results demonstrate that nobiletin markedly suppressed microglial activation characterized by overproduction and release of NO (Fig. 2) and pro-inflammatory cytokine TNF-alpha (Fig. 3) . Activation of ERK, JNK, p38 MAPKs (Fig. 4) , and NF-kB signaling pathways (Fig. 5) were significantly inhibited by nobiletin treatment in LPS-stimulated BV-2 microglial cells.
Consistent with previous reports on the signal pathways underlying microglial activation, 11, 12) we observed that MAPKs such as ERK, JNK and p38, NF-kB signal pathways and proinflammatory mediator NO and TNF-a were involved in LPS-stimulated BV-2 microglial activation. We found all of these signal pathways to be significantly suppressed in nobiletin-treated BV-2 microglial cells, suggesting novel anti-neuroinflammatory activity of nobiletin on suppression of LPS-induced microglial activation. BV-2 microglia exhibit phenotypic and functional properties comparable to those of primary microglia. The experimental results shown in primary microglia culture are almost same to those accomplished in BV-2 microglia in many studies 28, 29) including our previous investigation. 30) Microglial cells have been shown to be activated by several endogenous and exogenous stimuli, including LPS, 29) glutamate, 30) thrombin, 31, 32) ganglioside, 33) and beta amyloid. 34) LPS, a type of cell wall compound toxin of gram-negative bacteria, is not a common cause of human neuroinflammation; however, the experimental model of LPS stimulation has been the most widely used because it has shown potent capacity to stimulate microglia and is the most established among the known microglial activators.
Overproduction of NO and pro-inflammatory cytokines such as TNF-a, IL-1b and IL-6 released by activated microglia induces neuronal death and damage to neighboring neurons in the brain. The microglia-mediated neurotoxicity has been demonstrated in many investigations including a mouse model of neuroinflammation using intraperitoneally injection of LPS, 12) and in vitro studies using a neuron-microglia co-culture model or a microglia-conditioned media method. 11, 29, 35) Therefore, microglial activation and subsequent neuroinflammation-mediated neurotoxicity is implicated as a target of therapeutic intervention not only in acute stroke injuries but also in chronic neurodegenerative diseases.
Inflammation exerts two opposite impacts in tissues and cells. Inflammation is basically a physiological response to recover damaged tissue and plays a role in innate immunity. However, inflammation turns into a pathophysiological condition which evokes diseases if it exceeds the cytotoxicity threshold. The initial causes evoking specific diseases are thought to be different in neuroinflammatory and neurodegenerative diseases such as ischemia, Parkinson's, Alzheimer's and ALS. However, neuroinflammation consequent to the initial causes (i.e., accumulation of beta amyloid, blockade of blood supply, etc.), shows common features regardless of disease entity. It is now generally accepted that neuroinflammation is a crucial factor actively involved in the Cell lysates were then prepared and subjected to 10% SDS-PAGE followed by Western blotting with antibodies specific for phosphorylated forms of ERK, JNK and p38 MAPK. initiation and progress of diseases.
Neuroinflammation, which is mainly mediated by activation of microglia, is able to deteriorate neural function via synaptic loss and dysfunction several years prior to severe neuronal death and damage. 36, 37) Inflammation decreased the number of N-methyl-D-aspartate receptors (NMDAR) within the dentate gyrus and CA3 hippocampal areas. 38) Inflammation impaired spatial memory and induction of synaptic plasticity including both long term potentiation (LTP) and depression (LTD) in perforant path-granule cell synapses. 37, 39) Several epidemiological cohort studies have demonstrated the reduced risk and delayed onset of Alzheimer's disease in non-steroidal anti-inflammatory drug (NSAID) users, [40] [41] [42] suggesting a neuroprotective effect of anti-inflammatory agents in the pathogenesis and progression of neurodegenerative diseases. Therefore, the suppression of microglial activation may be an effective therapeutic strategy to alleviate the progression of neuroinflammatory and neurodegenerative diseases.
Citrus fruit-derived flavonoids and their metabolites have significant biological activities, including anti-inflammatory properties. The dried peels have been used as herbal medicines to improve bronchial asthma, dyspepsia and cardiac circulation. 20) Nobiletin, a polymethoxylated flavone exclusively found in the fruit peel of Citrus, is the most potent among tested citrus flavonoids in inhibitory activity of NO production in stimulated RAW 264.7 cells, a macrophage cell line. 20) Recently, a growing body of evidence has demonstrated the biological activity of nobiletin in the central nervous system. Nobiletin enhanced neurite outgrowth in PC12D cells by activating ERK/MAP kinase-dependent signaling to increase CREB phosphorylation. 21) Nobiletin enhanced PKAmediated phosphorylation of AMPA receptor subunit GluR1 and postsynaptically augmented field excitatory postsynaptic potential (fEPSP) in hippocampal slice related to cellular mechanisms of learning and memory. 43) Nobiletin rescued impaired memory in olfactory-bulbectomized mice accompanied by cholinergic neurodegeneration and reversed olfactory bulbectomy-induced reduction of acetylcholinesterase and choline acetyltransferase. 22) Nobiletin improved learning and memory impairment in several brain disease models, such as a N-ethyl-D-aspartate receptor antagonism model, 44) an ischemia animal model with bilateral common carotid artery occlusion (BCCAO), 24) and an amyloid precursor protein (APP) transgenic mouse model which over expresses human APP 695 harboring the double Swedish and London mutation.
23) The effects of nobiletin on cognitive functions shown in these brain disease models were related to phosphorylation of ERK/MAP kinase, CREB and CaMKII.
In conclusion, we demonstrated that citrus nobiletin suppresses microglial activation in LPS-stimulated BV-2 microglial cell culture model. Even though several studies have been tried to explore the neuroprotective mechanism of nobiletin, it remains to be fully elucidated. Anti-neuroinflammatory activity of nobiletin on suppression of brain insultinduced excessive microglial activation was suggested as one of the neuroprotective mechanisms in the present study. These results may contribute to further exploration of the therapeutic potential and molecular mechanism of nobiletin in relation to neuroinflammation and neurodegenerative diseases.
